What is the Global Health Ltd share price today?

The share price of NSE:MEDANTA-EQ on 01 Oct 2026 (as of 15:04:14 IST) is ₹1359.3.

What is the NSE:MEDANTA-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:MEDANTA-EQ 52 week high low range shows a high of ₹1544 and a low of ₹956.

What is the Global Health Ltd market cap?

As on 01 Oct 2026, Global Health Ltd market cap is ₹366893000000.

What is the shareholding pattern of Global Health Ltd Stock?

The shareholding pattern of Global Health Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 33% Foreign Institutional Investors (FII): 9.46% Domestic Institutional Investors (DII): 0.86% Mutual Funds: 16.03% Retail & Others: 40.65% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Global Health Ltd?

The Price-to-Earnings (PE) ratio of Global Health Ltd is 65.9668, and the Price-to-Book (PB) ratio is 6.55, as on 01 Oct 2026.

Global Health Share Price

1393.90+68.10 (+5.14%)

+9.36% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+5.14%

1 Week

+9.73%

1 Month

+4.60%

3 Month

-3.49%

6 Month

+16.10%

YTD

+17.49%

1 Year

+9.36%

5 Year

10 Year

Max

+247.61%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1326.60

1270.30

1165.00

1153.00

956.00

High

1423.60

1544.00

About

Global Health, operating under the Medanta brand, is engaged in the business of providing healthcare services. The company delivers a comprehensive range of services across several medical specialties, including cardiac Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MAXHEALTHNSE

MANIPALHOSNSE

ASTERDMNSE

FORTISNSE

NHNSE

MEDANTANSE

LALPATHLABNSE

KIMSNSE

AGARWALEYENSE

LTP

1W Low

1W High

Market cap (₹)

8502.5+54.5 (0.65%)

8301

8575

1,21,412Cr

917.7+57.7 (6.71%)

863.80

926.70

87,015Cr

665.85-3.3 (-0.49%)

633.25

670.45

84,796Cr

690.55+9.4 (1.38%)

672

693.45

59,431Cr

789.4+21.25 (2.77%)

754.65

795.50

59,227Cr

1899.4+179.2 (10.42%)

1732.50

1926

38,205Cr

1391+120.7 (9.50%)

1270.30

1423.60

35,671Cr

1924.4+18 (0.94%)

1856.50

1939.40

32,373Cr

734.95+33.15 (4.72%)

702.40

746.80

30,682Cr

522.55+13.35 (2.62%)

502

525.50

16,250Cr

Global Health Share Price

1393.90+68.10 (+5.14%)

+9.36% past 1 Year

Financial overview

Compounded Sales Growth

10 years12%

5 years25%

3 years18%

Last year19%

Compounded Profit Growth

10 years13%

5 years81%

3 years20%

Last year15%

Stock Price CAGR

10 years-

5 years-

3 years18%

1 year4%

Return on Equity

10 years10%

5 years16%

3 years16%

Last year15%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
12%	25%	18%	19%
13%	81%	20%	15%
-	-	18%	4%
10%	16%	16%	15%

Peer Comparison

Symbol

APOLLOHOSP

MAXHEALTH

MANIPALHOS

ASTERDM

FORTIS

MEDANTA

LALPATHLAB

KIMS

AGARWALEYE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
8,518.5	₹121412 Cr	58.11	40.39	207.67	₹1942 Cr
916.75	₹87015 Cr	63.03	4.26	19.36	₹1442 Cr
666.85	₹84796 Cr	95.03	1.96	11.95	₹892 Cr
697.4	₹59431 Cr	186.49	0.31	6.76	₹388 Cr
787.8	₹59227 Cr	56.52	3.53	20.1	₹1042 Cr
1,914.6	₹38205 Cr	44.49	14.73	71.14	₹806 Cr
1,394.5	₹35671 Cr	57.68	8.21	32.95	₹556 Cr
1,915.8	₹32373 Cr	59.74	10.11	42.51	₹505 Cr
733.35	₹30682 Cr	150.18	1.04	12.74	₹241 Cr
521.35	₹16250 Cr	109.52	1.43	13.88	₹133 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
₹1469 Cr	₹1304 Cr	₹1159 Cr	₹1121 Cr	₹1099 Cr	₹1031 Cr	₹931 Cr	₹943 Cr	₹957 Cr	₹861 Cr	₹809 Cr	₹836 Cr	₹850 Cr	₹780 Cr	₹707 Cr	₹694 Cr	₹679 Cr	₹617 Cr	₹521 Cr	₹583 Cr
₹24 Cr	₹22 Cr	₹37 Cr	₹22 Cr	₹20 Cr	₹20 Cr	₹23 Cr	₹16 Cr	₹18 Cr	₹22 Cr	₹27 Cr	₹18 Cr	₹14 Cr	₹15 Cr	₹25 Cr	₹12 Cr	₹16 Cr	₹9 Cr	₹12 Cr	₹10 Cr
₹1493 Cr	₹1326 Cr	₹1196 Cr	₹1143 Cr	₹1119 Cr	₹1051 Cr	₹954 Cr	₹959 Cr	₹975 Cr	₹883 Cr	₹836 Cr	₹855 Cr	₹865 Cr	₹794 Cr	₹732 Cr	₹706 Cr	₹695 Cr	₹627 Cr	₹533 Cr	₹593 Cr
₹1170 Cr	₹1086 Cr	₹982 Cr	₹965 Cr	₹918 Cr	₹849 Cr	₹756 Cr	₹754 Cr	₹778 Cr	₹721 Cr	₹675 Cr	₹664 Cr	₹674 Cr	₹636 Cr	₹578 Cr	₹573 Cr	₹560 Cr	₹521 Cr	₹476 Cr	₹481 Cr
₹394 Cr	₹309 Cr	₹281 Cr	₹239 Cr	₹251 Cr	₹247 Cr	₹248 Cr	₹254 Cr	₹247 Cr	₹208 Cr	₹207 Cr	₹234 Cr	₹234 Cr	₹199 Cr	₹192 Cr	₹172 Cr	₹172 Cr	₹142 Cr	₹92 Cr	₹146 Cr
₹28 Cr	₹27 Cr	₹27 Cr	₹22 Cr	₹17 Cr	₹14 Cr	₹15 Cr	₹16 Cr	₹16 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹20 Cr	₹18 Cr	₹20 Cr	₹21 Cr	₹18 Cr	₹19 Cr	₹28 Cr	₹18 Cr
₹295 Cr	₹213 Cr	₹187 Cr	₹120 Cr	₹200 Cr	₹208 Cr	₹133 Cr	₹189 Cr	₹181 Cr	₹144 Cr	₹143 Cr	₹172 Cr	₹171 Cr	₹141 Cr	₹133 Cr	₹112 Cr	₹117 Cr	₹87 Cr	₹29 Cr	₹95 Cr
₹219 Cr	₹157 Cr	₹142 Cr	₹95 Cr	₹158 Cr	₹159 Cr	₹101 Cr	₹143 Cr	₹131 Cr	₹106 Cr	₹127 Cr	₹124 Cr	₹125 Cr	₹102 Cr	₹101 Cr	₹81 Cr	₹86 Cr	₹59 Cr	₹18 Cr	₹70 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
—	—	—	—	—	—	—	—	—	—	—	—
₹54 Cr	₹54 Cr	₹54 Cr	₹54 Cr	₹51 Cr	₹82 Cr	₹82 Cr	₹82 Cr	₹81 Cr	₹81 Cr	₹81 Cr	₹80 Cr
₹16 Cr	₹25 L	₹4 Cr	₹5 Cr	₹6 Cr	₹32 Cr	₹48 Cr	₹54 Cr	₹74 Cr	₹42 Cr	₹12 Cr	₹5 Cr
₹3891 Cr	₹3332 Cr	₹2848 Cr	₹2369 Cr	₹1560 Cr	₹1268 Cr	₹1219 Cr	₹1170 Cr	₹1062 Cr	₹1016 Cr	₹964 Cr	₹794 Cr
₹3891 Cr	₹3332 Cr	₹2848 Cr	₹2369 Cr	₹1560 Cr	₹1268 Cr	₹1219 Cr	₹1170 Cr	₹1062 Cr	₹1016 Cr	₹964 Cr	₹794 Cr
₹3962 Cr	₹3386 Cr	₹2906 Cr	₹2428 Cr	₹1616 Cr	₹1382 Cr	₹1350 Cr	₹1305 Cr	₹1217 Cr	₹1139 Cr	₹1057 Cr	₹879 Cr
₹23 Cr	₹1 Cr	-₹3 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹49 L	₹51 L
₹601 Cr	₹264 Cr	₹236 Cr	₹659 Cr	₹717 Cr	₹551 Cr	₹541 Cr	₹449 Cr	₹229 Cr	₹24 Cr	₹113 Cr	₹40 Cr
₹0	₹0	₹48 Cr	₹78 Cr	₹50 Cr	₹26 Cr	₹65 Cr	₹140 Cr	₹107 Cr	₹108 Cr	₹0	₹0
-₹16 Cr	-₹33 Cr	-₹37 Cr	-₹7 Cr	-₹28 Cr	-₹26 Cr	₹8 Cr	₹31 Cr	₹48 Cr	₹57 Cr	₹61 Cr	₹62 Cr
₹579 Cr	₹430 Cr	₹415 Cr	₹305 Cr	₹291 Cr	₹287 Cr	₹309 Cr	₹25 Cr	₹31 Cr	₹36 Cr	₹2 Cr	₹6 Cr
₹114 Cr	₹66 Cr	₹58 Cr	₹54 Cr	₹555 Cr	₹461 Cr	₹86 Cr	₹31 Cr	₹17 Cr	₹17 Cr	₹13 Cr	₹11 Cr
₹1278 Cr	₹727 Cr	₹719 Cr	₹1089 Cr	₹1586 Cr	₹1300 Cr	₹1009 Cr	₹676 Cr	₹432 Cr	₹242 Cr	₹189 Cr	₹118 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹242 Cr	₹195 Cr	₹187 Cr	₹195 Cr	₹134 Cr	₹132 Cr	₹131 Cr	₹126 Cr	₹106 Cr	₹104 Cr	₹92 Cr	₹83 Cr
₹355 Cr	₹377 Cr	₹394 Cr	₹352 Cr	₹266 Cr	₹245 Cr	₹208 Cr	₹143 Cr	₹134 Cr	₹109 Cr	₹110 Cr	₹108 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹67 Cr	₹30 Cr	₹11 Cr	₹0
₹30 Cr	₹47 Cr	₹36 Cr	₹26 Cr	₹19 Cr	₹28 Cr	₹19 Cr	₹10 Cr	₹27 Cr	₹28 Cr	₹26 Cr	₹23 Cr
₹627 Cr	₹619 Cr	₹618 Cr	₹573 Cr	₹419 Cr	₹405 Cr	₹358 Cr	₹279 Cr	₹334 Cr	₹272 Cr	₹238 Cr	₹214 Cr
₹5889 Cr	₹4733 Cr	₹4243 Cr	₹4090 Cr	₹3622 Cr	₹3087 Cr	₹2716 Cr	₹2259 Cr	₹1984 Cr	₹1653 Cr	₹1485 Cr	₹1212 Cr
₹100 Cr	₹89 Cr	₹52 Cr	₹47 Cr	₹24 Cr	₹13 Cr	₹12 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹0	₹0
₹631 Cr	₹328 Cr	₹419 Cr	₹842 Cr	₹838 Cr	₹645 Cr	₹622 Cr	₹610 Cr	₹423 Cr	₹183 Cr	₹133 Cr	₹48 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹5077 Cr	₹3605 Cr	₹3146 Cr	₹2877 Cr	₹2458 Cr	₹2173 Cr	₹2141 Cr	₹1359 Cr	₹1328 Cr	₹1126 Cr	₹1223 Cr	₹991 Cr
₹1283 Cr	₹1091 Cr	₹910 Cr	₹827 Cr	₹682 Cr	₹557 Cr	₹438 Cr	₹329 Cr	₹239 Cr	₹154 Cr	₹309 Cr	₹239 Cr
₹3795 Cr	₹2514 Cr	₹2236 Cr	₹2050 Cr	₹1776 Cr	₹1616 Cr	₹1703 Cr	₹1030 Cr	₹1089 Cr	₹972 Cr	₹914 Cr	₹752 Cr
₹132 Cr	₹529 Cr	₹386 Cr	₹327 Cr	₹439 Cr	₹464 Cr	₹382 Cr	₹656 Cr	₹317 Cr	₹10 Cr	₹12 Cr	₹23 Cr
₹3 Cr	₹3 Cr	₹5 L	₹5 L	₹5 L	₹5 L	₹0	₹0	₹5 Cr	₹5 Cr	₹0	₹0
₹3 Cr	₹3 Cr	₹5 L	₹5 L	₹5 L	₹5 L	₹0	₹0	₹5 Cr	₹5 Cr	₹0	₹0
₹144 Cr	₹120 Cr	₹93 Cr	₹100 Cr	₹583 Cr	₹486 Cr	₹128 Cr	₹79 Cr	₹74 Cr	₹35 Cr	₹15 Cr	₹10 Cr
₹141 Cr	₹30 Cr	₹18 Cr	₹34 Cr	₹12 Cr	₹19 Cr	₹25 Cr	₹4 Cr	₹28 Cr	₹2 Cr	₹35 Cr	₹17 Cr
₹4214 Cr	₹3200 Cr	₹2734 Cr	₹2511 Cr	₹2810 Cr	₹2585 Cr	₹2237 Cr	₹1769 Cr	₹1512 Cr	₹1025 Cr	₹976 Cr	₹802 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹79 Cr	₹67 Cr	₹67 Cr	₹60 Cr	₹53 Cr	₹40 Cr	₹39 Cr	₹23 Cr	₹23 Cr	₹21 Cr	₹28 Cr	₹25 Cr
₹411 Cr	₹292 Cr	₹215 Cr	₹194 Cr	₹180 Cr	₹134 Cr	₹149 Cr	₹164 Cr	₹152 Cr	₹107 Cr	₹75 Cr	₹53 Cr
₹1130 Cr	₹1122 Cr	₹1175 Cr	₹1278 Cr	₹512 Cr	₹289 Cr	₹250 Cr	₹266 Cr	₹260 Cr	₹470 Cr	₹376 Cr	₹304 Cr
₹19 Cr	₹24 Cr	₹17 Cr	₹19 Cr	₹46 Cr	₹23 Cr	₹32 Cr	₹23 Cr	₹23 Cr	₹17 Cr	₹17 Cr	₹10 Cr
₹36 Cr	₹28 Cr	₹34 Cr	₹28 Cr	₹20 Cr	₹16 Cr	₹9 Cr	₹14 Cr	₹14 Cr	₹13 Cr	₹13 Cr	₹17 Cr
₹1675 Cr	₹1533 Cr	₹1509 Cr	₹1579 Cr	₹812 Cr	₹502 Cr	₹479 Cr	₹490 Cr	₹472 Cr	₹627 Cr	₹509 Cr	₹410 Cr
₹1048 Cr	₹914 Cr	₹891 Cr	₹1007 Cr	₹392 Cr	₹97 Cr	₹121 Cr	₹212 Cr	₹138 Cr	₹355 Cr	₹271 Cr	₹196 Cr
₹5889 Cr	₹4733 Cr	₹4243 Cr	₹4090 Cr	₹3622 Cr	₹3087 Cr	₹2716 Cr	₹2259 Cr	₹1984 Cr	₹1653 Cr	₹1485 Cr	₹1212 Cr
₹147	₹126	₹108	₹90	₹64	₹266	₹257	₹248	₹229	₹219	₹210	₹177
₹147	₹126	₹108	₹90	₹64	₹53	₹51	₹50	₹46	₹44	₹42	₹35

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
₹715 Cr	₹647 Cr	₹627 Cr	₹449 Cr	₹281 Cr	₹32 Cr	₹64 Cr	₹95 Cr	₹60 Cr	₹85 Cr	₹262 Cr	₹226 Cr
₹204 Cr	₹240 Cr	₹208 Cr	₹199 Cr	₹195 Cr	₹189 Cr	₹165 Cr	₹120 Cr	₹123 Cr	₹107 Cr	₹78 Cr	₹65 Cr
-₹85 Cr	-₹100 Cr	-₹46 Cr	₹103 Cr	-₹67 Cr	₹37 Cr	₹2 Cr	₹3 Cr	-₹66 Cr	-₹19 Cr	-₹15 Cr	-₹24 Cr
₹834 Cr	₹788 Cr	₹790 Cr	₹751 Cr	₹409 Cr	₹258 Cr	₹231 Cr	₹218 Cr	₹116 Cr	₹173 Cr	₹325 Cr	₹267 Cr
₹714 Cr	₹624 Cr	₹612 Cr	₹645 Cr	₹311 Cr	₹242 Cr	₹175 Cr	₹150 Cr	₹63 Cr	₹115 Cr	₹228 Cr	₹213 Cr
-₹1089 Cr	-₹721 Cr	-₹441 Cr	-₹342 Cr	-₹421 Cr	-₹239 Cr	-₹87 Cr	-₹243 Cr	-₹69 Cr	-₹107 Cr	-₹241 Cr	-₹126 Cr
₹272 Cr	-₹97 Cr	-₹514 Cr	₹346 Cr	₹160 Cr	-₹81 Cr	-₹88 L	₹113 Cr	₹9 Cr	-₹6 Cr	-₹7 Cr	-₹87 Cr
-₹103 Cr	-₹194 Cr	-₹343 Cr	₹648 Cr	₹50 Cr	-₹78 Cr	₹87 Cr	₹19 Cr	₹3 Cr	₹2 Cr	-₹20 Cr	-₹32 L
₹230 Cr	₹425 Cr	₹767 Cr	₹119 Cr	₹69 Cr	₹148 Cr	₹60 Cr	₹47 Cr	₹44 Cr	₹42 Cr	₹62 Cr	₹63 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹20,000	₹0	₹0	₹0
₹127 Cr	₹230 Cr	₹425 Cr	₹767 Cr	₹119 Cr	₹69 Cr	₹148 Cr	₹66 Cr	₹47 Cr	₹44 Cr	₹43 Cr	₹62 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Global Health Share Price

1393.90+68.10 (+5.14%)

+9.36% past 1 Year

Shareholding summary

Promoters

33%

FII

9.92%

DII

1.04%

15.97%

Others

40.07%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
33.00%	33.00%	33.01%	33.01%	33.01%	33.01%
9.92%	9.46%	10.15%	10.54%	11.41%	11.54%
1.04%	0.86%	0.85%	0.87%	1.14%	1.54%
15.97%	16.03%	13.91%	13.12%	11.83%	10.66%
40.07%	40.65%	42.08%	42.46%	42.61%	43.25%

Bulk & block deals

Name

Hdfc Mutual Fund

Sunil Sachdeva

Hdfc Mutual Fund

Sunil Sachdeva

Rj Corp Limited

Jm Financial Institutional Securities Limited

Dunearn Investments Mauritius Pte Limited

The Jupiter Global Fund-Jupiter India Select

Jupiter South Asia Investment Company Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
25 Jun 2026	Purchase	130 Cr	₹1,300	10 L	Block	0.37193	BSE
25 Jun 2026	Sell	130 Cr	₹1,300	10 L	Block	0.37193	BSE
25 May 2026	Purchase	122.50 Cr	₹1,225	10 L	Block	0.371952	NSE
25 May 2026	Sell	122.50 Cr	₹1,225	10 L	Block	0.371952	NSE
14 Feb 2024	Purchase	379.01 Cr	₹1,315	28.82 L	Bulk	1.07195	BSE
14 Feb 2024	Sell	394.51 Cr	₹1,315.05	30 L	Bulk	1.115761	BSE
14 Feb 2024	Purchase	394.57 Cr	₹1,315.22	30 L	Bulk	1.115761	BSE
14 Feb 2024	Sell	394.56 Cr	₹1,315.20	30 L	Bulk	1.115761	BSE
18 Jan 2024	Purchase	30.67 Cr	₹1,030.05	2.98 L	Block	0.110755	BSE
18 Jan 2024	Sell	30.67 Cr	₹1,030.05	2.98 L	Block	0.110755	BSE

Insider trading & SAST

Client name

Invesco Mutual Fund

Sunil Sachdeva

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Mar 2026	Other	Acquisition	0.37	5.02	—	10.02 L	20 Feb 2026	Market	1,35,13,011	SAST	29(1)	—
28 Oct 2025	Other	Acquisition	3.24	11.15	—	87.10 L	30 Sep 2025	Off Market Transfer	2,99,91,884	SAST	29(2)	—
24 Jun 2025	Other	Acquisition	7.92	11.27	—	2.13 Cr	16 May 2025	Off Market Transfer	3,02,64,524	SAST	29(2)	—

Global Health Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Global Health Share Price

Global Health Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Global Health Share Price

Global Health Share Price

Oscillators

Moving averages

Global Health Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Global Health Share Price

Corporate Actions

Company details

Global Health Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Global Health Share Price

News

Medanta Reports Strong Q2 EBITDA Growth With Improved Operating Margin

Medanta Q2 Consolidated Net Profit Rises 39 Percent Year On Year

Medanta Q2 Revenue Rises 34 Percent Year on Year To Rs 1,470 Crores

Global Health Secures Land For New 350 Plus Bedded Hospital

Global Health Schedules Analyst and Investor Meeting for September 25

Investec starts Buy on Global Health with Rs 1,730 target price

Global Health to host investor and analyst meetings on September 17-18

Global Health plans investor and analyst meeting on September 14

Global Health schedules analyst and investor meetings on 10 and 14 September

Global Health to host analyst and investor meet on September 8

Global Health MEDANTA schedules analyst and investor meet on August 21

Global Health Ltd sees Rs 19.96 crores NSE block trade in MEDANTA

Medanta expects stronger volume growth in Lucknow and Patna, higher Gurgaon expansion

Global Health approves revised Guwahati hospital plan with 650 beds

Global Health posts higher Q1 EBITDA with stable margin performance

Global Health Q1 revenue surges while profit remains flat year on year

Global Health schedules Q1 FY2025 earnings conference call for investors

Global Health, Medanta operator to review Q1 FY26 results on July 30

Global Health gets LoI from Government of Haryana

Global Health Limited: Gets Intent Letter From Haryana Government To Set Up Medical College; Will Provide 150 Mbbs Seats At Medanta – The Medicity, Gurugram.

Global Health Ltd Share Price Today

Global Health Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator